Attenuation of Post-infarct LV Remodeling by Mechanical Unloading Using Impella-CP

  • STATUS
    Recruiting
  • End date
    Dec 31, 2023
  • participants needed
    80
  • sponsor
    Institute for Clinical and Experimental Medicine
Updated on 25 January 2021
Investigator
Marek Sramko, MD, PhD
Primary Contact
Institute for Clinical and Experimental Medicine (IKEM) (1.2 mi away) Contact
heart failure
infarct
ischemia
SPECT Scan
revascularisation

Summary

Patients with anterior wall AMI treated by PCI will undergo, after successful revascularization of the infarct artery, measurement of the left ventricular pressure, and femoral angiogram. Patients with elevated LV pressure and adequate femoral access will be randomized to standard pharmacological treatment of AMI vs. mechanical unloading by Impella-CP (on top of the standard treatment) for 36-48 hours. LV unloading will be guided by measurement of PCWP by Swan-Ganz catheter. On the day 4-7, and at 3 months after the AMI, the patients will undergo SPECT and 3D-echocardiography to assess ventricular remodeling and extent of the post-infarct scar. The patients will be followed for at least 12 months for the occurrence of heart failure and adverse cardiovascular events. The study will test the hypothesis, whether the LV mechanical unloading after PCI will attenuate post-infarct scar and cardiac remodeling.

Description

  1. Eligible patients with be screened before PCI
  2. The patients with undergo coronary angiography and PCI according to common medical practice
  3. At the end of the PCI procedure, after a successful revascularization, a pigtail catheter will be used to measure LV filling pressure and to perform femoral angiography (to evaluate femoral access).
  4. Patients fulfilling angiographic and hemodynamic criteria will be randomized 1:1 to standard care vs. mechanical unloading by Impella-CP.
  5. The patients will be treated on a CCU with experience with use of Impella-CP.
  6. On the CCU, all patients will be monitored by a Swan-Ganz catheter for 48 hours.
  7. The pump speed will be adjusted to maintain the lowest tolerated PCWP while avoiding suction events.
  8. Mechanical unloading will last 36-48h. Afterwards, the Impella-CP will be explanted.
  9. All patients will receive standard pharmacotherapy of AMI, according to the guidelines.
  10. Revascularization of significant non-infarct lesions will be performed during the index hospitalization.
  11. 3D-echocardiography and Tc-SPECT (D-SPECT) will be performed on the day 5-7 of the index hospitalization. LV phasic volumes and extent of nonperfused myocardium (scar) will be evaluated automatically, using software provided by the vendor.
  12. 3D-echocardiography and Tc-SPECT will be repeated at 3 months after the AMI.
  13. The patients will be followed by out-patient check-ups every 12 months.

Details
Condition Myocardial Infarction, Cardiogenic shock, Ventricular Remodeling, Ischemic Heart Disease, Heart Attack (Myocardial Infarction), Cardiac Ischemia, Myocardial Ischemia, heart attack, myocardial infarction (mi), cardiac infarction, heart attacks, myocardial necrosis
Treatment LV mechanical unloading by Impella-CP
Clinical Study IdentifierNCT04562272
SponsorInstitute for Clinical and Experimental Medicine
Last Modified on25 January 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

large anterior wall AMI with estimated ischemia of <24h
at risk of the beginning of cardiogenic shock (SCAI A/B)
blood pressure <160/100 mmHg
no previous IM based on the patient's history
no previously known LV systolic dysfunction
assumed new LV dysfunction documented by ECHO or LVG (LVEF < 45%)
infarct culprit lesion at the proximal LAD, LMCA or equivalent, with TIMI <= 2 flow
LV end-diastolic pressure of >= 18 mmHg measured invasively

Exclusion Criteria

history of chronic LV dysfunction
chronic anticoagulation therapy
the need of IIb/IIIa blockers at the PCI
inadequate femoral vein access (peripheral artery disease)
significant valve disease or valve prosthesis
CPR >5 min before PCI
LV thrombus
periprocedural AMI (obliteration of large non-culprit artery during PCI)
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

0/250
Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note